Cefadroxil
- Product NDC
- 65862-085
- 11-digit product format
- 658620085
- Labeler code
- 65862
- Product ID
- 65862-085_58128541-059d-4ef1-9dbf-98fa1befdcf0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefadroxil
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA065352
- Marketing category
- ANDA
- Marketing start
- 2007-01-25
- Substance
- CEFADROXIL
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefadroxil
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFADROXIL | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 280111G160 |
| Rxcui | 309049 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65862-085-01 | Cefadroxil | 100 in 1 BOTTLE | CAPSULE | 100 | | 13 |
| 65862-085-50 | Cefadroxil | 50 in 1 BOTTLE | CAPSULE | 50 | | 13 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFADROXIL | ACTIVE INGREDIENT | 280111G160 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| CEFADROXIL ANHYDROUS | ACTIVE MOIETY | Q525PA8JJB | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| CEFADROXIL | ACTIVE INGREDIENT | 280111G160 | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| CEFADROXIL ANHYDROUS | ACTIVE MOIETY | Q525PA8JJB | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 7 | |
| CEFADROXIL | ACTIVE INGREDIENT | 280111G160 | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| CEFADROXIL | ACTIVE MOIETY | 280111G160 | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFADROXIL CAPSULE [STAT RX USA LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65862-085 | CEFADROXIL CAPSULE [AUROBINDO PHARMA LIMITED] | 13 | Current NDC, Legacy NDC, 2 package rows | 20240131_7bb90096-14d3-400e-94d3-048bff6b1292.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-085-01 | 65862008501 | 100 CAPSULE in 1 BOTTLE (65862-085-01) | 100 capsule | 2007-01-25 | 0000-00-00 | No | No | Current |
| 65862-085-12 | 65862008512 | 1200 CAPSULE in 1 BAG (65862-085-12) | 1200 capsule | 25-JAN-07 | | | | Current |
| 65862-085-50 | 65862008550 | 50 CAPSULE in 1 BOTTLE (65862-085-50) | 50 capsule | 2007-01-25 | 0000-00-00 | No | No | Current |